NDC 51862-102-01 - Camila
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51862-102
- Requested NDC
- 51862-102-01
- Package NDCs from labels
- 51862-102-01, 51862-102-06
- Manufacturer
- Mayne Pharma Inc. | Teva Pharmaceuticals USA, Inc.
- Effective date
- 2018-10-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Camila ® (norethindrone tablets USP, 0.35 mg) | Mayne Pharma Inc. | Teva Pharmaceuticals USA, Inc. | 2018-10-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51862-102-01 | EA - Each | 51862-102 | 654cd1b0-0377-4425-92e8-4b83fab15ef6 | 1 | 2017-05-03 |
| 51862-102-06 | EA - Each | 51862-102 | b918672e-15bc-4b3d-804d-367186897561 | 1 | 2016-09-02 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Incassia | NORETHINDRONE | Aurobindo Pharma Limited | 0b87cef0-610c-469d-92ba-4007f4bc3878 | 2021-09-14 | Warnings, Adverse reactions | T18F433X4S |
| Norethindrone | NORETHINDRONE | Proficient Rx LP | fb84b86e-5f1f-4c17-8b69-ff695c5faf55 | 2019-11-01 | Warnings, Adverse reactions | T18F433X4S |
| NORETHINDRONE | NORETHINDRONE | Mylan Pharmaceuticals Inc. | af851d82-b30f-463b-9dba-0437225dc1ee | 2018-10-23 | Boxed warning, Warnings, Adverse reactions | T18F433X4S |
| 4e7d704c-562d-4b01-b700-931fd28b68cb | 8cedd2ff-473d-4a8e-87d1-9758cc19238a | 2018-10-17 | Warnings, Adverse reactions | 4e7d704c-562d-4b01-b700-931fd28b68cb 8cedd2ff-473d-4a8e-87d1-9758cc19238a |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.